I

Instil Bio Inc
NASDAQ:TIL

Watchlist Manager
Instil Bio Inc
NASDAQ:TIL
Watchlist
Price: 10.84 USD -1.09% Market Closed
Market Cap: 73.5m USD

EV/EBIT
Enterprise Value to EBIT

-1.5
Current
-2.6
Median
7
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-1.5
=
Enterprise Value
78.5m USD
/
EBIT
-53.9m USD
All Countries
Close
EBIT Growth EV/EBIT to Growth
US
I
Instil Bio Inc
NASDAQ:TIL
Average EV/EBIT: 45.2
Negative Multiple: -1.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 906.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.7
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.3
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.9
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.4
13%
1.4
AU
CSL Ltd
ASX:CSL
16.1
11%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
191.6
N/A N/A
NL
argenx SE
XBRU:ARGX
58.2
N/A N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-0.9
2-Years Forward
EV/EBIT
-0.7
3-Years Forward
EV/EBIT
-0.9